Vulvar cancer is a relatively rare gynecologic malignancy with an annual incidence in
developed countries of approximately 2 per 100,000 women. Vulvar squamous cell …

The majority of patients with vulvar cancer have squamous cell carcinomas (SCC). The
cornerstone of the treatment is surgery. Radical vulvectomy with “en bloc” inguinofemoral …

Objective There is great need for better risk stratification in vulvar squamous cell carcinoma
(VSCC). Our aim was to define the prognostic significance of stratifying VSCC based on p16 …

During the last decades there has been a continuing evolution in the surgical approach of
squamous cell carcinoma of the vulva that has been traditionally treated with radical …

Background There is no consensus on the width of tumour-free margins after surgery for
vulvar squamous cell carcinoma (VSCC). Most current guidelines recommend tumour-free …

Abstract Recurrent disease occurs in 12–37% of patients with vulvar squamous cell
carcinoma (VSCC). Decisions about treatment of recurrent VSCC mainly depend on the …

Purpose: Patients with advanced or recurrent invasive vulvar squamous cell carcinoma
(VSCC) have limited treatment options and a grave prognosis. Understanding the genomic …

Purpose: This is an official guideline, published and coordinated by the Arbeitsgemeinschaft
Gynäkologische Onkologie (AGO, Study Group for Gynecologic Oncology) of the Deutsche …

Background. An increase in vulvar cancer in young women is attributed to infection with
oncogenic human papillomavirus (HPV). South Africa (SA) has a high prevalence of HPV …

Surgery is the mainstay of treatment for vulvar cancer. FIGO staging requires
histopathological detail of the primary tumor and inguinofemoral lymph nodes but groin …